Bio-Rad Laboratories Class A
387 hedge funds and large institutions have $7.02B invested in Bio-Rad Laboratories Class A in 2019 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 136 increasing their positions, 111 reducing their positions, and 44 closing their positions.
157% more call options, than puts
Call options by funds: $27.9M | Put options by funds: $10.8M
86% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 44
23% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 111
9% more capital invested
Capital invested by funds: $6.43B → $7.02B (+$593M)
9% more funds holding
Funds holding: 355 → 387 (+32)
1.4% less ownership
Funds ownership: 78.17% → 76.77% (-1.4%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
+$80.6M |
| 2 |
BlackRock
New York
|
+$77.5M |
| 3 |
State Street
Boston,
Massachusetts
|
+$55M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$52.8M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$48.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$123M |
| 2 |
Millennium Management
New York
|
-$71.3M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$53.4M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$42M |
| 5 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
-$38.4M |
BIO Hedge Fund Activity: Q4 2019 in Review
387 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2019, worth a combined $7.02B — up 9.2% from $6.43B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new BIO positions and 44 closed out — a net gain of 38 holders — while 136 added to existing stakes and 111 trimmed.
The largest buyer was Brown Advisory, opening a new position worth an estimated $80.6M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $123M sold.
- 387 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2019, up from 355 in Q3 2019.
- Funds reported $7.02B of Bio-Rad Laboratories Class A stock for Q4 2019, up 9.2% quarter-over-quarter.
- 82 funds opened new Bio-Rad Laboratories Class A positions in Q4 2019 and 44 closed out, a net change of +38 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q4 2019 was Brown Advisory, an estimated $80.6M added.
- The largest Bio-Rad Laboratories Class A seller in Q4 2019 was Acadian Asset Management, an estimated $123M sold.
Based on aggregated 13F filings for Q4 2019.